Wyatt McDonnell, CEO and co-founder of Infinimmune. Early-stage biotechnology company Infinimmune, which is developing novel techniques for antibody drug discovery and development, announced that it ...

Monoclonal antibodies (mAbs) contain N-linked glycans that influence pharmacokinetics and efficacy, making glycoform ...

A research team created a new way to sort living cells suspended in fluid using an all-in-one operation in a lab-on-chip that required only 30 minutes for the entire separation process. This device ...

An alternative and complementary method for the confirmation of COVID-19 infection involves the detection of SARS-CoV-2-specific antibodies. Testing strips based on gold nanoparticles are currently in ...

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a new initiative to significantly reduce, refine, and replace animal testing ...

DURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma, Inc. (Inhalon), a clinical-stage company advancing a first-in-class inhaled antibody platform for treating acute respiratory infections (ARI), today ...